Company

Strike Pharma AB

Biotechnology Research Uppsala, Uppsala Län, Se 20 employees

Employees: 20
Contacts: 3
Emails: 3

LinkedIn Crunchbase

Strike Pharma AB Overview

Headquarters: Uppsala, Uppsala Län, Se
Industry: Biotechnology Research
Employees: 20
Founded: 2020
Funding: 4.8M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Immunotherapy Immuno-oncology Drug Development Personalized medicine CAR-T

About Strike Pharma AB

Strike Pharma is using its proprietary technology for targeted nanoparticle delivery to enable in vivo CAR-T therapy. The lead candidate, STR3/19, is based on a lipid nanoparticle that carries mRNA for an anti-CD19 CAR that is selectively delivered to T cells via an anti-CD3 antibody. This is an off-the-shelf alternative to current CAR-T therapies, that reprogrammes T cells to B-cell depleting CAR-Ts inside the body and that is intended for treatment of B-cell dependent autoimmune disease, such as SLE, and for B-cell lymphoma. Strike Pharma was founded in 2020, has Eir Ventures and Flerie Invest as major shareholders, and is headquartered at Smile Venture Hub, Medicon Village, Lund, Sweden.

Strike Pharma AB Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Strike Pharma AB Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tina Furebring	Early Drug Development/project Management/people Management	Lund, Skåne County, Sweden	Email
Wing Cheng	Program Manager @ Uic - Board Member - Senior Advisor - Pricing & Market Access - Life Science Strategy		View
Gunilla Ekström	Co-founder and VP Project Management at Gesynta Pharma Ab	Greater Stockholm Metropolitan Area, Sweden	Email
Pierre Dönnes	CEO at Scicross Ab, Honorary Professor at Ucl	Sweden	Email